Leucovorin Mitigates Mucositis in Patients Treated with FOLOTYN.
Hey, when stating it this way
comes across much better and to the point as opposed to the abstract released a month ago
Also note they tested patients that had CTCL. I guess when nothing else is working in CTCL, they'll use Folotyn which can have positive results in some patients.
Anyhows, this trial was a strong topic of discussion when it was initiated years ago since one problem with Folotyn effectiveness was patients stopping treatment early due to AEs and if they stop treatment early you get less revenue. This data shows they can stay on treatment and revenue will increase correspondingly. It will be interesting to see the trend in Folotyn use/revenue in the next year or so (i.e if you get $8m in revenue now will it be $12m in the future?). I would think they'll work on getting a sNDA for a label change on use, but even if don't I'm sure any onc doc who uses Folotyn will be adding leucovorin. Very positive for Folotyn.